|
Delayed
Nasdaq
23:34:18 18/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.8450 USD | -1.04% |
|
-8.15% | +21.99% |
| 11-06 | Elutia Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 11-06 | Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 37.91M 34.57M 31.97M 28.85M 54.33M 3.54B 56.48M 386M 153M 1.91B 142M 139M 6.04B | P/E 2026 * |
-1.29x | P/E 2027 * | -1.36x |
|---|---|---|---|---|---|
| Enterprise Value | 37.91M 34.57M 31.97M 28.85M 54.33M 3.54B 56.48M 386M 153M 1.91B 142M 139M 6.04B | EV / Sales 2026 * |
5.05x | EV / Sales 2027 * | 8.82x |
| Free-Float |
85.22% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ELUT | Delayed | |
| ELUT | Real-time |
Last Transcript: Elutia Inc.
| 1 day | -1.63% | ||
| 1 week | -8.15% | ||
| Current month | +0.94% | ||
| 1 month | +3.66% | ||
| 3 months | -7.14% | ||
| 6 months | -23.18% | ||
| Current year | +21.99% |
| 1 week | 0.79 | 0.94 | |
| 1 month | 0.7 | 0.96 | |
| Current year | 0.6 | 1.38 | |
| 1 year | 0.5 | 1.38 | |
| 3 years | 0.5 | 5.24 | |
| 5 years | 0.5 | 9.01 | |
| 10 years | 0.5 | 18.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Operating Officer | 52 | - | |
Charles Mills
CEO | Chief Executive Officer | 54 | 21/06/2022 |
Matthew Ferguson
DFI | Director of Finance/CFO | 58 | 28/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Rakin
CHM | Chairman | 65 | 01/11/2015 |
Charles Mills
BRD | Director/Board Member | 54 | 01/11/2015 |
Brigid Makes
BRD | Director/Board Member | 70 | 01/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/10/26 A | Exercice | Founder | 63,884 | 0.1445% | ||
| 9/10/26 A | Exercice | Founder | 29,269 | 0.0662% | ||
| 9/10/26 A | Exercice | Chief Financial Officer | 29,486 | 0.0667% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.04% | -8.15% | +21.36% | -47.84% | 37.82M | ||
| -2.21% | -3.65% | +34.45% | +131.74% | 1,261B | ||
| -1.94% | -2.44% | +36.78% | +82.48% | 671B | ||
| -2.32% | -2.94% | +22.42% | +107.00% | 518B | ||
| -0.69% | +0.40% | +40.46% | +69.78% | 387B | ||
| -3.81% | -6.26% | +43.07% | +34.36% | 353B | ||
| -1.35% | -2.23% | +24.30% | +56.34% | 300B | ||
| -1.13% | -1.71% | +0.40% | +33.00% | 283B | ||
| -3.12% | -5.02% | +29.25% | +67.56% | 248B | ||
| -0.60% | -0.29% | +33.06% | +122.67% | 211B | ||
| Average | -1.93% | -0.48% | +28.55% | +65.71% | 423B | |
| Weighted average by Cap. | -2.06% | -0.55% | +31.25% | +90.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.5M 6.84M 6.32M 5.71M 10.75M 701M 11.17M 76.38M 30.19M 378M 28.14M 27.55M 1.19B | 4.3M 3.92M 3.63M 3.27M 6.16M 402M 6.41M 43.79M 17.31M 217M 16.13M 15.79M 685M |
| Net income | -27.3M -24.9M -23.02M -20.77M -39.13M -2.55B -40.67M -278M -110M -1.38B -102M -100M -4.35B | -23.6M -21.52M -19.9M -17.96M -33.82M -2.21B -35.16M -240M -95.01M -1.19B -88.54M -86.68M -3.76B |
| Net Debt | - | - |
Employees
26
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | $0.8450 | -1.04% | 11,689 |
| 17/11/26 | $0.8539 | +3.77% | 49,962 |
| 16/11/26 | $0.8229 | +0.35% | 53,867 |
| 13/11/26 | $0.8200 | -6.69% | 50,439 |
| 12/11/26 | $0.8788 | -4.48% | 83,188 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8539USD
Average target price
5.000USD
Spread / Average Target
+485.55%
- Stock Market
- Stocks
- ELUT Stock
Select your edition
All financial news and data tailored to specific country editions
















